17-48728454-T-C
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006361.6(HOXB13):c.140A>G(p.Asn47Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,613,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N47K) has been classified as Uncertain significance.
Frequency
Consequence
NM_006361.6 missense
Scores
Clinical Significance
Conservation
Publications
- prostate cancerInheritance: AD Classification: DEFINITIVE Submitted by: Illumina
- prostate cancer, hereditary, 9Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HOXB13 | NM_006361.6 | c.140A>G | p.Asn47Ser | missense_variant | Exon 1 of 2 | ENST00000290295.8 | NP_006352.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HOXB13 | ENST00000290295.8 | c.140A>G | p.Asn47Ser | missense_variant | Exon 1 of 2 | 1 | NM_006361.6 | ENSP00000290295.8 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152214Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000201 AC: 5AN: 249214 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.000111 AC: 162AN: 1460954Hom.: 0 Cov.: 33 AF XY: 0.000111 AC XY: 81AN XY: 726760 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74366 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 47 of the HOXB13 protein (p.Asn47Ser). This variant is present in population databases (rs748333323, gnomAD 0.006%). This missense change has been observed in individual(s) with prostate cancer (PMID: 22781434). ClinVar contains an entry for this variant (Variation ID: 483487). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The HOXB13 c.140A>G (p.Asn47Ser) variant has been reported in the published literature in an individual with prostate cancer (PMID: 22781434 (2012)). The frequency of this variant in the general population, 0.000063 (8/127812 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. -
In silico analysis indicates that this missense variant does not alter protein structure/function; Observed in an individual with a personal history of prostate cancer in published literature (PMID: 22781434); This variant is associated with the following publications: (PMID: 28272408, 22781434) -
Prostate cancer, hereditary, 9 Uncertain:1
- -
HOXB13-related disorder Uncertain:1
The HOXB13 c.140A>G variant is predicted to result in the amino acid substitution p.Asn47Ser. This variant was reported in an individual with prostate cancer (Akbari et al. 2012. PubMed ID: 22781434). This variant is reported in 0.0063% of alleles in individuals of European (Non-Finnish) descent in gnomAD and is interpreted as a variant of uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/483487/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.140A>G (p.N47S) alteration is located in exon 1 (coding exon 1) of the HOXB13 gene. This alteration results from a A to G substitution at nucleotide position 140, causing the asparagine (N) at amino acid position 47 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at